In race to Covid-19 drugs, EU may fast track remdesivir sale before US
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Sunday
July 03, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
SUNDAY, JULY 03, 2022
In race to Covid-19 drugs, EU may fast track remdesivir sale before US

Coronavirus chronicle

Reuters
18 May, 2020, 06:55 pm
Last modified: 18 May, 2020, 07:21 pm

Related News

  • China slashes Covid quarantine time for international travellers
  • Indonesia to drop outdoor mask mandate as Covid-19 infections drop
  • WHO: Covid-19 falling everywhere, except Americas and Africa
  • N Korea reports first Covid-19 outbreak, orders lockdown
  • 34 volunteers chose to get covid. Here’s what scientists learned

In race to Covid-19 drugs, EU may fast track remdesivir sale before US

Demand for remdesivir has been growing as there are currently no approved treatments or vaccines for Covid-19, the respiratory illness caused by the new coronavirus

Reuters
18 May, 2020, 06:55 pm
Last modified: 18 May, 2020, 07:21 pm
An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters
An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters

The European Union may give an initial green light in the coming days for sale of the drug remdesivir as a Covid-19 treatment, the head of its medicines agency said on Monday, fast-tracking the drug to market amid tight global competition for resources.

The United States, which has angered the EU with aggressive tactics in a procurement race during the global pandemic, has yet to issue a similar approval for the drug, made by US pharmaceutical company Gilead.

Demand for remdesivir has been growing as there are currently no approved treatments or vaccines for Covid-19, the respiratory illness caused by the new coronavirus.

"It might be that a conditional market(ing) authorisation can be issued in the coming days," the head of the European Union's medicines agency Guido Rasi said on Monday at a hearing in the EU Parliament in Brussels.

An EU conditional marketing authorisation allows a drug to be sold for a year in the 27-nation bloc before all necessary data are available on its efficacy and side effects.

The European Medicines Agency (EMA) has already recommended the compassionate use of remdesivir, which allows a drug to be administered to patients even before its sale has been authorised.

EMA's recommendation on compassionate use matched an emergency authorisation granted by the US Food and Drug Administration (FDA) earlier in May, after Gilead provided data showing the drug had helped Covid-19 patients.

But the EU is now moving rapidly to the next step in the authorisation procedure.

The equivalent procedure in the US is called "accelerated approval", as opposed to the standard authorisation that the FDA grants to medicines which pass all tests before their marketing.

As pressure mounts to ramp up production of the drug, Gilead has said it was in discussions with chemical and drug manufacturers to produce remdesivir for Europe and Asia until at least 2022.

The company is also negotiating long-term licenses with several generic drugmakers in India and Pakistan to produce remdesivir for developing countries.

But it is still unclear how soon sufficient amounts of the drug could be available to meet the world's need for a treatment.

Apart from remdesivir, Rasi said other possible treatments against Covid-19 that may be available quickly are those based on monoclonal antibodies, which can "neutralise" the new coronavirus that causes Covid-19.

He also warned that Europe could face shortages of a Covid-19 vaccine if it were developed in a year's time, echoing concerns raised by EU health ministers and officials earlier in May.

Because the vaccine could be developed outside of the EU, and the bloc's production capacity may be insufficient to meet all needs, he said the EU should have a common strategy to deliver shots first to people most in need, such as medics and nurses.

Top News

Coronavirus

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Export earnings hit record high $52.08B in FY22
    Export earnings hit record high $52.08B in FY22
  • Remittance inflow down by 15% in FY21-22 
    Remittance inflow down by 15% in FY21-22 
  • Photo of Bangladesh Secretariat/Collected
    Govt stops purchasing new cars for ministries, departments

MOST VIEWED

  • A man helps his son to wear mask at Covid-19 test centre at KSRTC bus stand in Bengaluru.(PTI)
    India records 16,103 new Covid cases, 31 deaths in 24 hours
  • Former North Korean defectors living in South Korea, release balloons containing one dollar banknotes, radios, CDs and leaflets denouncing the North Korean regime, towards the north near the demilitarized zone which separates the two Koreas in Paju, north of Seoul January 15, 2014. REUTERS/Kim Hong-Ji/File Photo
    North Korea blames 'alien things' near border with South for Covid outbreak
  • People wearing protective face masks commute amid concerns over the new coronavirus disease (COVID-19) in Pyongyang, North Korea March 30, 2020, in this photo released by Kyodo. Picture taken March 30, 2020. Mandatory credit Kyodo/via REUTERS
    S Korea says leaflets sent by defectors unlikely to be cause of Covid in N Korea
  • Test tubes are seen in front of displayed Pfizer and Biontech logos in this illustration taken, May 21, 2021. Reuters: llustration
    BioNTech, Pfizer to start testing universal vaccine for coronaviruses
  • A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
    S Korea approves first domestically developed Covid vaccine
  • Photo: Collected
    US medical experts call for Omicron-specific Covid boosters

Related News

  • China slashes Covid quarantine time for international travellers
  • Indonesia to drop outdoor mask mandate as Covid-19 infections drop
  • WHO: Covid-19 falling everywhere, except Americas and Africa
  • N Korea reports first Covid-19 outbreak, orders lockdown
  • 34 volunteers chose to get covid. Here’s what scientists learned

Features

A Glittery Eid

A Glittery Eid

4h | Mode
Rise’s target customers are people who crave to express themselves through what they wear, and their clothing line is not relegated to any age range.

Level up your Eid game with Rise

5h | Mode
Stefan Dercon, a Professor of Economics at the University of Oxford and former Chief Economist of the Department of International Development (DFID). Illustration: TBS

Renewing the ‘elite bargain’ for Bangladesh’s future growth

7h | Panorama
The eye-catching commuter: Suzuki Gixxer SF 155

The eye-catching commuter: Suzuki Gixxer SF 155

1d | Wheels

More Videos from TBS

Chirkutt performs on Fete de La Music Fest

Chirkutt performs on Fete de La Music Fest

6h | Videos
Madhuri Sanchita's seed ornaments exhibition

Madhuri Sanchita's seed ornaments exhibition

6h | Videos
Bangabandhu Tunnel to change lives of million

Bangabandhu Tunnel to change lives of million

18h | Videos
Sowari Ghat's fresh fish market

Sowari Ghat's fresh fish market

18h | Videos

Most Read

1
Padma Bridge from satellite. Photo: Screengrab
Bangladesh

Padma Bridge from satellite 

2
Meet the man behind 'Azke amar mon balo nei'
Splash

Meet the man behind 'Azke amar mon balo nei'

3
TBS Illustration
Education

Universities may launch online classes again after Eid

4
Photo: TBS
Bangladesh

Motorcycles banned on Padma Bridge 

5
Photo: Collected
Economy

Tech startup ShopUp bags $65m in Series B4 funding

6
World Bank to give Bangladesh $18b IDA loans in next five years
Economy

World Bank to give Bangladesh $18b IDA loans in next five years

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab
BENEATH THE SURFACE
Launch operators on various river routes see a steep drop in passengers after the opening of the the Padma Bridge. Photo: TBS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net